Brief Culturally Adapted CBT for OCD
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-65
SponsorPakistan Association of Cognitive Therapists
About this trial
The purpose aims to assess the efficacy of Brief Culturally Adapted Cognitive Behaviour Therapy (Ca-CBT) for the treatment of Obsessive Compulsive Disorder (OCD).
Eligibility criteria
This trial accepts healthy volunteersQualifiers
Participants aged 18 years or above
Participants with at least an elementary level of reading and writing
Clinical diagnosis of Obsessive Compulsive Disorder, either alone or comorbid with depression or anxiety
Disqualifiers
Participants with excessive use of alcohol or drugs (using ICD-10 RDC for alcohol or drug abuse or dependence)
Those with significant cognitive impairment (for example, intellectual disability or dementia)
Or those with OCD comorbid active psychosis
Trial design
Design model
Parallel
Treatments tested in this trial
Brief culturally adapted cognitive behaviour therapy (CaCBT)
Other interventionThe intervention will focus on psychoeducation, symptom management, Exposure and Response prevention (ERP), thought distraction techniques, relaxation exercises, detection of mood and thoughts, cognitive errors, changing negative thinking, behavioural activation, problem solving, improving relationships and communication skills, Thought diaries and progress diary.
Treatment groups
166 Participants
are divided into 2 treatment groupsGroup A: Brief culturally adapted CBT (CaCBT) groupExperimental treatment 1 intervention
Group B: Treatment as usual groupNo intervention 0 interventions
Trial outcomes
Primary outcomes
1
Efficacy of brief culturally adapted cognitive behaviour therapy (CaCBT) for OCD
By comparing pre- and post-treatment OCD scores measured through the Yale-Brown Obsessive-Compulsive Scale (Y-BOCS).
Time frame
6 weeks2
Acceptability of the brief culturally adapted cognitive behaviour therapy (CaCBT) for OCD
Feedback will be taken from both patients and their family members, who will be trained as co-therapists, to evaluate their satisfaction with the therapy.
Time frame
6 weeksSecondary outcomes
1
Reduction in depression and anxiety associated with OCD
By comparing pre- and post-treatment depression and anxiety scores measured through the Hospital Anxiety and Depression Scale (HADS).
Time frame
6 weeks2
Reduction in functioning decline associated with OCD
By comparing pre- and post-treatment scores on the Brief Disability Questionnaire (BDQ).
Time frame
6 weeksSponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov